130 related articles for article (PubMed ID: 7074574)
1. Adenocarcinoma and mixed carcinoma of the uterine cervix. II. Prognostic value of nuclear DNA analysis.
Fu YS; Reagan JW; Fu AS; Janiga KE
Cancer; 1982 Jun; 49(12):2571-7. PubMed ID: 7074574
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis.
Welch WR; Fu YS; Robboy SJ; Herbst AL
Gynecol Oncol; 1983 Apr; 15(2):230-8. PubMed ID: 6832636
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA ploidy and morphometric analyses of adenocarcinoma of the uterine cervix.
Fu YS; Hall TL; Berek JS; Hacker NF; Reagen JW
Anal Quant Cytol Histol; 1987 Mar; 9(1):17-24. PubMed ID: 3580081
[TBL] [Abstract][Full Text] [Related]
4. [An analysis of nuclear DNA histogram of adenocarcinoma of the uterine cervix].
Yoshida K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):723-8. PubMed ID: 2768967
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
6. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
[TBL] [Abstract][Full Text] [Related]
8. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.
Alfsen GC; Kristensen GB; Skovlund E; Pettersen EO; Abeler VM
Cancer; 2001 Nov; 92(9):2471-83. PubMed ID: 11745305
[TBL] [Abstract][Full Text] [Related]
9. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
10. Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib.
Jakobsen A; Bichel P; Kristensen GB; Nyland M
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):969-72. PubMed ID: 3409946
[TBL] [Abstract][Full Text] [Related]
11. Quantitative nuclear DNA analysis of human ovarian adenocarcinoma: compared before and after chemotherapy and correlated with clinical response.
Dobashi K; Stratton JA; Teplitz RL; Liao SY; Braly PS; Disaia PJ
Gynecol Oncol; 1986 May; 24(1):81-90. PubMed ID: 3754529
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
13. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
16. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
[TBL] [Abstract][Full Text] [Related]
17. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus.
Atkin NB
J Natl Cancer Inst; 1976 May; 56(5):909-10. PubMed ID: 994202
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma and mixed carcinoma of the uterine cervix. I. A. clinicopathologic study.
Fu YS; Reagan JW; Hsiu JG; Storaasli JP; Wentz WB
Cancer; 1982 Jun; 49(12):2560-70. PubMed ID: 7074573
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometry (FCM) in DNA content assay of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content--II. Results].
Wu AR
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):194-6. PubMed ID: 3219979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
